To What Extent Can Biosimilars Compete with Brand Name Biologics? A EU-5 Granulocyte-Colony Stimulating Factors Markets Analysis
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.763
https://www.valueinhealthjournal.com/article/S1098-3015(13)02668-5/fulltext
Title :
To What Extent Can Biosimilars Compete with Brand Name Biologics? A EU-5 Granulocyte-Colony Stimulating Factors Markets Analysis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)02668-5&doi=10.1016/j.jval.2013.08.763
First page :
A455
Section Title :
Health Care Use & Policy Studies
Open access? :
No
Section Order :
731